The first living patient to receive a transplant kidney pig genetically modified patient died, announced the US hospital Mass General Hospitalwho carried out the intervention.
“Mass General is deeply saddened by the sudden passing of Mr. Rick Slayman. “We have no indication that it was the result of his recent transplant,” the hospital located in Boston (northeast) said in a statement.
In March, surgeons at Mass General Hospital (MGH) performed an unprecedented procedure in the world for about four hours on this 62-year-old man who suffered from end-stage kidney disease.
The hospital declared late Saturday that “Slayman will forever be remembered as a beacon of hope for countless transplant patients around the world and we are deeply grateful to him for his trust and willingness to advance the xenotransplantation sector.”
Organ shortages are a chronic problem around the world, and the Boston hospital declared in March that it had more than 1,400 patients on the waiting list for a kidney transplant.
The pig kidney used for the transplant was provided by a Massachusetts biotechnology company called eGenesis, which genetically modified it to remove harmful genes and add some human genes, the hospital stated.
Rick Slayman, who suffered from type 2 diabetes and hypertension, had received a human kidney in 2018, but this organ had begun to stop functioning five years later and the patient was undergoing dialysis.
It may interest you
- They discover what causes kidney fibrosis, a step towards future treatments
- Technological advances in the treatment of Diabetes: new alternatives and costs
- Experimental pig collagen corneas restore sight to 20 people
Source: Gestion
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
